Clinical Trial Update: Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining interactions between Lopinavir/Ritonavir and oral or patch contraceptives in HIV-infected women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pregnancy

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• oral or patch contraceptives (contraceptives)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Pregnancy | Phase 2 | Status: COMPLETED